Category: September 2019

Is The DEA Branching Out Into Regulating Medicine?

Dr. Jeffrey Singer Reprinted with permission of the author and the Cato Institute. Dr. Jeffrey Singer’s original essay can be found here. The Drug Enforcement Administration, having virtually eliminated the diversion of prescription pain relievers into the underground market for nonmedical users, appears to be setting its sights on regulating the medical management of pain,…

Pain Management Resources Washington Clarification Letter on 2017 Opioid Rules was Washington State Boards, Commissions and the Department of Health have composed a letter to clarify the 2017 opioid prescribing rules. We have received reports of patients on chronic opioid therapy whose opioids have been rapidly tapered or discontinued. We are also hearing reports of…